Sanofi Takes Sun To Court Over Generic Eloxatin
Sanofi-Aventis SA filed a suit Friday in New Jersey seeking to block Sun Pharmaceutical Industries Ltd. from launching a generic version of the French drugmaker's colorectal cancer treatment Eloxatin before August...To view the full article, register now.
Already a subscriber? Click here to view full article